Aromando Andrew, Chief Business Officer of Oncolytics Biotech Inc. ($ONCY), made one open market purchase of common shares in the last 365 days, totaling $25,417.52. His most recent buy occurred on February 11, 2026. This ranks him 3,574th among 4,983 insiders in our database by purchase amount, below the average of $1.46 million across 3.29 transactions. Andrew reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | ONCOLYTICS BIOTECH INC | $ONCY | Aromando Andrew | Chief Business Officer | P | Common Shares | 29600 | $0.86 | 55,100.0000 | 80,020,131 | 116.08% | 0.04% |